| Article Access Statistics|
| Viewed||2183 |
| Printed||14 |
| Emailed||0 |
| PDF Downloaded||20 |
| Comments ||[Add] |
Click on image for details.
|Year : 2018 | Volume
| Issue : 2 | Page : 583-584
Bias in randomized trials
Sunil K Raina
Department of Community Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, India
|Date of Web Publication||15-Mar-2018|
Dr. Sunil K Raina
Department of Community Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Raina SK. Bias in randomized trials. Neurol India 2018;66:583-4
I went through with interest the article entitled “A randomized placebo-controlled trial of progesterone with or without hypothermia in patients with acute severe traumatic brain injury”, published in Neurology India (2017;65:1304-11). The authors deserve credit for their efforts.
Randomized controlled trials (RCTs) with a robust study design are viewed as the “gold standard” for comparing different interventions, as when performed correctly, randomization guarantees an unbiased estimate of the treatment effect. The authors seem to have taken care of the robustness of the design by performing “blinding and allocation concealment” in recruitment. However, the study design of this study used restricted randomization as the authors recruited 107 patients in four groups in a ratio of 1:1.
I would like to share my concerns with the authors regarding the design of this study. RCTs despite using adequate allocation concealment suffer from selection bias. This selection bias arises from restricted randomization (as used by authors in this study). Restricted randomization forces the treatment groups to be similar in some manner, for example, by requiring that a similar number of patients are assigned to each treatment group. This means that the imbalance between groups (intervention and control) can never be more than two patients. It has been reported that when the imbalance between groups is 1, the recruiter will be able to correctly guess the next allocation with 83% probability; when the imbalance is 2, this probability increases to 100%. The answer lies in conducting simple randomization (sometimes also referred to as “complete” or “unrestricted” randomization). Simple randomization works by assigning each patient to one of the treatment groups with a certain probability (usually 50%). This probability (50%) is the same for every patient, regardless of previous allocations. For example, in a trial where 30 of the first 40 patients were assigned to the intervention group and only 10 to the control group, when the 31st patient presents for randomization, the patient would still have an equal chance of being assigned to either treatment groups, regardless of the imbalance in numbers. As the probability stays the same, recruiters or allocators will not be able to guess with any accuracy which treatment the patient will be assigned to (as they would essentially be trying to guess the results of a coin-flip). This reduces selection bias. Agreed that simple randomization is infrequently used in practice probably to provide a balance in the number of patients assigned to each treatment group,, the fact remains that, provided the overall sample size is not too small, this lack of balance has only a very small impact on power and should not be used as a reason to avoid simple randomization.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| » References|| |
Sinha S, Raheja A, Samson N, Goyal K, Bhoi S, Selvi A, Sharma BS. A randomized placebo-controlled trial of progesterone with or without hypothermia in patients with acute severe traumatic brain injury. Neurol India 2017;65:1304-11.
] [Full text]
Kahan BC, Rehal S, Cro S. Risk of selection bias in randomised trials. Trials 2015;16:405.
Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: Review and reanalysis. BMJ 2012;345:e5840.
Hewitt CE, Torgerson DJ. Is restricted randomisation necessary? BMJ 2006;332:1506-8.
Rosenberger WF, Lachin JM. Randomization in clinical trials. Chichester: Wiley; 2005.